Squamous cell carcinoma of pancreas

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:424039C25.0C25.1C25.2
Who is this for?
Show terms as
1FDA treatments2Active trials17Specialists8Treatment centers1Financial resources

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Squamous cell carcinoma of the pancreas is a very rare type of pancreatic cancer. Most pancreatic cancers are a type called adenocarcinoma, which starts in gland cells. Squamous cell carcinoma, by contrast, starts in flat, scale-like cells that are not normally found in the pancreas — making this an unusual and poorly understood cancer. It may also be called pancreatic squamous cell carcinoma or primary squamous cell carcinoma of the pancreas. Because it is so rare, it is sometimes grouped under the broader term 'rare exocrine pancreatic tumors.' The pancreas sits deep in the abdomen and plays two main roles: helping digestion and controlling blood sugar. When a tumor grows in the pancreas, it can block nearby structures like the bile duct or digestive tract, causing a range of symptoms. Common symptoms include yellowing of the skin and eyes (jaundice), belly or back pain, unexplained weight loss, poor appetite, nausea, and new-onset diabetes. Because the pancreas is located deep inside the body, symptoms often appear late, when the cancer has already grown or spread. Treatment options are similar to other pancreatic cancers and may include surgery to remove the tumor (if caught early enough), chemotherapy, and radiation therapy. However, because squamous cell carcinoma of the pancreas is so rare, there are no treatment guidelines specifically designed for it, and most care is based on what works for other pancreatic cancers. The outlook is generally poor, especially when the cancer is found at an advanced stage.

Also known as:

Key symptoms:

Yellowing of the skin and whites of the eyes (jaundice)Pain in the upper belly or backUnexplained weight lossLoss of appetiteNausea or vomitingNew or worsening diabetesFatigue and weaknessDark urinePale or greasy stoolsFeeling full quickly when eatingBloating or digestive discomfort

Inheritance

Sporadic

Usually appears on its own, not inherited from a parent

Age of Onset

Adult

Begins in adulthood (age 18 or older)

Orphanet ↗NORD ↗

FDA & Trial Timeline

6 events
Nov 2025A Study of STRO-004 in Adults With Refractory/Recurrent Metastatic Cancer

Sutro Biopharma, Inc. — PHASE1

TrialRECRUITING
Apr 2025A Study of GI-108, an Anti-CD73-IgG4 Fc-IL-2v Bispecific Fusion Protein, as Monotherapy in Patients With Advanced or Metastatic Solid Tumors

GI Innovation, Inc. — PHASE1, PHASE2

TrialRECRUITING
Jan 2025A Study of Evofosfamide in Combination with Zalifrelimab and Balstilimab

ImmunoGenesis — PHASE1, PHASE2

TrialRECRUITING
Jul 2024Feasibility of Auricular Acupressure for Appetite and Weight in Patients With Stage II-IV Gastric, Esophageal, and Pancreatic Cancer

University of Washington — NA

TrialRECRUITING
Jul 2023Phase 2 Futibatinib in Combination With PD-1 Antibody Based Standard of Care in Solid Tumors

Taiho Oncology, Inc. — PHASE2

TrialACTIVE NOT RECRUITING
Oct 2021A Study in Advanced or Metastatic Gastrointestinal Cancers Exploring Treatment Combinations With Pelareorep and Atezolizumab

Oncolytics Biotech — PHASE1, PHASE2

TrialRECRUITING

Data sourced from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.

Treatments

1 available

Alimta

pemetrexed disodium· Eli Lilly and Company
as a single agent for the maintenance treatment of patients with locally advanced or metastatic, non-squamous NSCLC whose disease has not progressed after four cycles of platinum-based first-line chem

as a single agent for the maintenance treatment of patients with locally advanced or metastatic, non-squamous NSCLC whose disease has not progressed after four cycles of platinum-based first-line chemotherapy

Clinical Trials

2 recruitingView all trials with filters →
Phase 21 trial
Phase 2 Futibatinib in Combination With PD-1 Antibody Based Standard of Care in Solid Tumors
Phase 2
Active
· Sites: Santa Monica, California; Denver, Colorado +20 more · Age: 1899 yrs

Specialists

17 foundView all specialists →
NM
Nina Merchant
Specialist
PI on 1 active trial
SP
Stefan Linder, MD, PhD
Specialist
PI on 1 active trial
RP
Robert Stagg, PharmD
Specialist
PI on 1 active trial
LM
Lin Shen, MD
Specialist
PI on 8 active trials1 Squamous cell carcinoma of pancreas publication
LM
Liu Yang, M.D.
Specialist
PI on 1 active trial
AM
Atif Khan, MD
Specialist
PI on 1 active trial
KM
Kuang-Yi Wen, MD
Specialist
PI on 1 active trial
DK
David Korn
DAVIE, FL
Specialist
PI on 1 active trial
JC
James Cleary
Specialist
PI on 1 active trial
GS
Geoffrey Shapiro
Specialist
PI on 1 active trial

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Financial Resources

1 resources
Alimta(pemetrexed disodium)Eli Lilly and Company

Travel Grants

No travel grants are currently matched to Squamous cell carcinoma of pancreas.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Squamous cell carcinoma of pancreasForum →

No community posts yet. Be the first to share your experience with Squamous cell carcinoma of pancreas.

Start the conversation →

Latest news about Squamous cell carcinoma of pancreas

Disease timeline:

New recruiting trial: A Study in Advanced or Metastatic Gastrointestinal Cancers Exploring Treatment Combinations With Pelareorep and Atezolizumab

A new clinical trial is recruiting patients for Squamous cell carcinoma of pancreas

New recruiting trial: A Study of STRO-004 in Adults With Refractory/Recurrent Metastatic Cancer

A new clinical trial is recruiting patients for Squamous cell carcinoma of pancreas

New recruiting trial: Feasibility of Auricular Acupressure for Appetite and Weight in Patients With Stage II-IV Gastric, Esophageal, and Pancreatic Cancer

A new clinical trial is recruiting patients for Squamous cell carcinoma of pancreas

New recruiting trial: A Study of Evofosfamide in Combination with Zalifrelimab and Balstilimab

A new clinical trial is recruiting patients for Squamous cell carcinoma of pancreas

New recruiting trial: A Study of GI-108, an Anti-CD73-IgG4 Fc-IL-2v Bispecific Fusion Protein, as Monotherapy in Patients With Advanced or Metastatic Solid Tumors

A new clinical trial is recruiting patients for Squamous cell carcinoma of pancreas

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Questions for your doctor

Bring these to your next appointment

  • Q1.Has the cancer spread beyond the pancreas, and what does that mean for my treatment options?,Is surgery possible in my case, and what are the risks and benefits?,Which chemotherapy regimen do you recommend for me, and what side effects should I expect?,Are there any clinical trials I might be eligible for given how rare this cancer type is?,Should I get a second opinion at a major cancer center that specializes in pancreatic cancer?,What palliative care or supportive services are available to help manage my symptoms?,How will we monitor whether the treatment is working?

Common questions about Squamous cell carcinoma of pancreas

What is Squamous cell carcinoma of pancreas?

Squamous cell carcinoma of the pancreas is a very rare type of pancreatic cancer. Most pancreatic cancers are a type called adenocarcinoma, which starts in gland cells. Squamous cell carcinoma, by contrast, starts in flat, scale-like cells that are not normally found in the pancreas — making this an unusual and poorly understood cancer. It may also be called pancreatic squamous cell carcinoma or primary squamous cell carcinoma of the pancreas. Because it is so rare, it is sometimes grouped under the broader term 'rare exocrine pancreatic tumors.' The pancreas sits deep in the abdomen and play

How is Squamous cell carcinoma of pancreas inherited?

Squamous cell carcinoma of pancreas follows a sporadic inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

At what age does Squamous cell carcinoma of pancreas typically begin?

Typical onset of Squamous cell carcinoma of pancreas is adult. Age of onset can vary across affected individuals.

Are there clinical trials for Squamous cell carcinoma of pancreas?

Yes — 2 recruiting clinical trials are currently listed for Squamous cell carcinoma of pancreas on UniteRare. See the clinical trials section on this page for phase, sponsor, and site details sourced from ClinicalTrials.gov.

Which specialists treat Squamous cell carcinoma of pancreas?

17 specialists and care centers treating Squamous cell carcinoma of pancreas are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.